The Raptiva Pregnancy Registry: An observational study of the use and safety of Raptiva (efalizumab) during pregnancy
Phase of Trial: Phase IV
Latest Information Update: 24 Nov 2014
At a glance
- Drugs Efalizumab (Primary)
- Indications Psoriasis
- Focus Adverse reactions
- Acronyms FOLLOW
- Sponsors Genentech
- 13 Feb 2010 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 13 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Sep 2009 New trial record.